Acg Wealth’s Bristol-Myers Squibb Co Position
Does Acg Wealth own Bristol-Myers Squibb Co (BMY)? Yes — 94.5K shares worth $7M (+1.54% of its 13F portfolio) as of Q3 2022, down from 97.3K shares the prior filed quarter.
Position Value
$7M
Q3 2022
Shares
94.5K
% of Portfolio
+1.54%
Quarters Held
13
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 94.5K | $7M | +1.54% |
| Q2 2022 | 97.3K | $7M | +1.53% |
| Q1 2022 | 96.9K | $7M | +1.34% |
| Q4 2021 | 113.7K | $7M | +1.01% |
| Q3 2021 | 139.2K | $8M | +1.08% |
| Q2 2021 | 139.4K | $9M | +1.18% |
| Q1 2021 | 135.3K | $9M | +1.13% |
| Q4 2020 | 125.8K | $8M | +1.08% |
| Q3 2020 | 125.1K | $8M | +1.14% |
| Q4 2019 | 127.9K | $8M | +1.22% |
| Q3 2019 | 72.5K | $4M | +0.54% |
| Q2 2019 | 67.9K | $3M | +0.41% |
| Q1 2019 | 98.1K | $5M | +0.63% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Acg Wealth’s full portfolio or all institutional holders of BMY.